Glycosyl-Phosphatidyl-Inositol (GPI)-anchors and metalloproteases: Their roles in the regulation of exosome composition and NKG2D-mediated immune recognition

Frontiers in Cell and Developmental Biology

Volumn 4, Issue SEP, 2016, Pages

  López Cobo, Sheila ^a   Campos Silva, Carmen ^a   Valés Gómez, Mar ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

DRMs; Exosomes; GPI anchored proteins; Immune evasion; Metalloproteases; MICA B; Shedding; ULBP

Indexed keywords

EID: 85019096850     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2016.00097     Document Type: Review

References (109)

1. Aguera-Gonzalez, S., Boutet, P., Reyburn, H. T., and Vales-Gomez, M. (2009). Brief residence at the plasma membrane of the MHC class I-related chain B is due to clathrin-mediated cholesterol-dependent endocytosis and shedding. J. Immunol. 182, 4800-4808. doi: 10.4049/jimmunol.0800713
2. Aguera-Gonzalez, S., Gross, C. C., Fernandez-Messina, L., Ashiru, O., Esteso, G., Hang, H. C., et al. (2011). Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding. Eur. J. Immunol. 41, 3667-3676. doi: 10.1002/eji.201141645
3. Altmeppen, H. C., Puig, B., Dohler, F., Thurm, D. K., Falker, C., Krasemann, S., et al. (2013). Proteolytic processing of the prion protein in health and disease. Am. J. Neurodegener. Dis. 1, 15-31
4. Armeanu, S., Bitzer, M., Lauer, U. M., Venturelli, S., Pathil, A., Krusch, M., et al. (2005). Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res. 65, 6321-6329. doi: 10.1158/0008-5472.CAN-04-4252
5. Ashiru, O., Boutet, P., Fernandez-Messina, L., Aguera-Gonzalez, S., Skepper, J. N., Vales-Gomez, M., et al. (2010). Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res. 70, 481-489. doi: 10.1158/0008-5472.CAN-09-1688
6. Ashiru, O., Lopez-Cobo, S., Fernandez-Messina, L., Pontes-Quero, S., Pandolfi, R., Reyburn, H. T., et al. (2013). A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008. Biochem. J. 454, 295-302. doi: 10.1042/BJ20130194
7. Bacon, L., Eagle, R. A., Meyer, M., Easom, N., Young, N. T., and Trowsdale, J. (2004). Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J. Immunol. 173, 1078-1084. doi: 10.4049/jimmunol.173.2.1078
8. Bahram, S., Bresnahan, M., Geraghty, D. E., and Spies, T. (1994). A second lineage of mammalian major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. U.S.A. 91, 6259-6263. doi: 10.1073/pnas.91.14.6259
9. Baragano Raneros, A., Martin-Palanco, V., Fernandez, A. F., Rodriguez, R. M., Fraga, M. F., Lopez-Larrea, C., et al. (2014a). Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia. Genes Immun. 16, 71-82. doi: 10.1038/gene.2014.58
10. Baragano Raneros, A., Suarez-Alvarez, B., and Lopez-Larrea, C. (2014b). Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention. Oncoimmunology 3:e28497. doi: 10.4161/onci.28497
11. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., et al. (1999). Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729. doi: 10.1126/science.285.5428.727
12. Boutet, P., Aguera-Gonzalez, S., Atkinson, S., Pennington, C. J., Edwards, D. R., Murphy, G., et al. (2009). Cutting edge: the metalloproteinase ADAM17/TNF-alpha-converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein. J. Immunol. 182, 49-53. doi: 10.4049/jimmunol.182.1.49
13. Butler, J. E., Moore, M. B., Presnell, S. R., Chan, H. W., Chalupny, N. J., and Lutz, C. T. (2009). Proteasome regulation of ULBP1 transcription. J. Immunol. 182, 6600-6609. doi: 10.4049/jimmunol.0801214
14. Chalupny, N. J., Sutherland, C. L., Lawrence, W. A., Rein-Weston, A., and Cosman, D. (2003). ULBP4 is a novel ligand for human NKG2D. Biochem. Biophys. Res. Commun. 305, 129-135. doi: 10.1016/S0006-291X(03)00714-9
15. Chavez-Blanco, A., De La Cruz-Hernandez, E., Dominguez, G. I., Rodriguez-Cortez, O., Alatorre, B., Perez-Cardenas, E., et al. (2011). Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate. Int. J. Oncol. 39, 1491-1499. doi: 10.3892/ijo.2011.1144
16. Chitadze, G., Bhat, J., Lettau, M., Janssen, O., and Kabelitz, D. (2013). Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications. Scand. J. Immunol. 78, 120-129. doi: 10.1111/sji.12072
17. Cichy, J., Rose-John, S., Potempa, J., Pryjma, J., and Travis, J. (1997). Oncostatin M stimulates the expression and release of the IL-6 receptor in human hepatoma HepG2 cells. J. Immunol. 159, 5648-5653
18. Clayton, A., Harris, C. L., Court, J., Mason, M. D., and Morgan, B. P. (2003). Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur. J. Immunol. 33, 522-531. doi: 10.1002/immu.200310028
19. Colombo, M., Raposo, G., and Thery, C. (2014). Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30, 255-289. doi: 10.1146/annurev-cellbio-101512-122326
20. Cosman, D., Mullberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., et al. (2001). ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14, 123-133. doi: 10.1016/S1074-7613(01)00095-4
21. Das, H., Groh, V., Kuijl, C., Sugita, M., Morita, C. T., Spies, T., et al. (2001). MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity 15, 83-93. doi: 10.1016/S1074-7613(01)00168-6
22. de Gassart, A., Geminard, C., Fevrier, B., Raposo, G., and Vidal, M. (2003). Lipid raft-associated protein sorting in exosomes. Blood 102, 4336-4344. doi: 10.1182/blood-2003-03-0871
23. Deng, W., Gowen, B. G., Zhang, L., Wang, L., Lau, S., Iannello, A., et al. (2015). Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection. Science 348, 136-139. doi: 10.1126/science.1258867
24. Duan, X., Mao, X., and Sun, W. (2013). ADAM15 is involved in MICB shedding and mediates the effects of gemcitabine on MICB shedding in PANC-1 pancreatic cancer cells. Mol. Med. Rep. 7, 991-997. doi: 10.3892/mmr.2013.1272
25. Dubois, L., Ronquist, K. K., Ek, B., Ronquist, G., and Larsson, A. (2015). Proteomic profiling of detergent resistant membranes (lipid rafts) of prostasomes. Mol. Cell. Proteomics 14, 3015-3022. doi: 10.1074/mcp.M114.047530
26. Eagle, R. A., Jafferji, I., and Barrow, A. D. (2009a). Beyond stressed self: evidence for NKG2D ligand expression on healthy cells. Curr. Immunol. Rev. 5, 22-34. doi: 10.2174/157339509787314369
27. Eagle, R. A., Traherne, J. A., Hair, J. R., Jafferji, I., and Trowsdale, J. (2009b). ULBP6/RAET1L is an additional human NKG2D ligand. Eur. J. Immunol. 39, 3207-3216. doi: 10.1002/eji.200939502
28. Esteso, G., Luzon, E., Sarmiento, E., Gomez-Caro, R., Steinle, A., Murphy, G., et al. (2014). Altered microRNA expression after infection with human cytomegalovirus leads to TIMP3 downregulation and increased shedding of metalloprotease substrates, including MICA. J. Immunol. 193, 1344-1352. doi: 10.4049/jimmunol.1303441
29. Fernandez-Messina, L., Ashiru, O., Aguera-Gonzalez, S., Reyburn, H. T., and Vales-Gomez, M. (2011). The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells. J. Cell Sci. 124, 321-327. doi: 10.1242/jcs.076042
30. Fernandez-Messina, L., Ashiru, O., Boutet, P., Aguera-Gonzalez, S., Skepper, J. N., Reyburn, H. T., et al. (2010). Differential mechanisms of shedding of the glycosylphosphatidylinositol (GPI)-anchored NKG2D ligands. J. Biol. Chem. 285, 8543-8551. doi: 10.1074/jbc.M109.045906
31. Fernandez-Messina, L., Reyburn, H. T., and Vales-Gomez, M. (2012). Human NKG2D-ligands: cell biology strategies to ensure immune recognition. Front. Immunol. 3:299. doi: 10.3389/fimmu.2012.00299
32. Fernandez-Messina, L., Reyburn, H. T., and Vales-Gomez, M. (2016). A short half-life of ULBP1 at the cell surface due to internalization and proteosomal degradation. Immunol. Cell Biol. 94, 479-485. doi: 10.1038/icb.2016.2
33. Fevrier, B., Vilette, D., Archer, F., Loew, D., Faigle, W., Vidal, M., et al. (2004). Cells release prions in association with exosomes. Proc. Natl. Acad. Sci. U.S.A. 101, 9683-9688. doi: 10.1073/pnas.0308413101
34. Ginestra, A., Monea, S., Seghezzi, G., Dolo, V., Nagase, H., Mignatti, P., et al. (1997). Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J. Biol. Chem. 272, 17216-17222. doi: 10.1074/jbc.272.27.17216
35. Gonzalez, S., Lopez-Soto, A., Suarez-Alvarez, B., Lopez-Vazquez, A., and Lopez-Larrea, C. (2008). NKG2D ligands: key targets of the immune response. Trends Immunol. 29, 397-403. doi: 10.1016/j.it.2008.04.007
36. Groh, V., Bahram, S., Bauer, S., Herman, A., Beauchamp, M., and Spies, T. (1996). Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. U.S.A. 93, 12445-12450. doi: 10.1073/pnas.93.22.12445
37. Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., and Spies, T. (2001). Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2, 255-260. doi: 10.1038/85321
38. Groh, V., Wu, J., Yee, C., and Spies, T. (2002). Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419, 734-738. doi: 10.1038/nature01112
39. Guerra, N., Pestal, K., Juarez, T., Beck, J., Tkach, K., Wang, L., et al. (2013). A selective role of NKG2D in inflammatory and autoimmune diseases. Clin. Immunol. 149, 432-439. doi: 10.1016/j.clim.2013.09.003
40. Han, K. Y., Dugas-Ford, J., Seiki, M., Chang, J. H., and Azar, D. T. (2014). Evidence for the involvement of MMP14 in MMP2 processing and recruitment in exosomes of corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 56, 5323-5329. doi: 10.1167/iovs.14-14417
41. Hawari, F. I., Rouhani, F. N., Cui, X., Yu, Z. X., Buckley, C., Kaler, M., et al. (2004). Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. Proc. Natl. Acad. Sci. U.S.A. 101, 1297-1302. doi: 10.1073/pnas.0307981100
42. Hayakawa, Y., Kelly, J. M., Westwood, J. A., Darcy, P. K., Diefenbach, A., Raulet, D., et al. (2002). Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin. J. Immunol. 169, 5377-5381. doi: 10.4049/jimmunol.169.10.5377
43. Hedlund, M., Stenqvist, A. C., Nagaeva, O., Kjellberg, L., Wulff, M., Baranov, V., et al. (2009). Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J. Immunol. 183, 340-351. doi: 10.4049/jimmunol.0803477
44. Heinemann, A., Zhao, F., Pechlivanis, S., Eberle, J., Steinle, A., Diederichs, S., et al. (2012). Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D. Cancer Res. 72, 460-471. doi: 10.1158/0008-5472.CAN-11-1977
45. Hilpert, J., Grosse-Hovest, L., Grunebach, F., Buechele, C., Nuebling, T., Raum, T., et al. (2012). Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses. J. Immunol. 189, 1360-1371. doi: 10.4049/jimmunol.1200796
46. Ikonen, E. (2001). Roles of lipid rafts in membrane transport. Curr. Opin. Cell Biol. 13, 470-477. doi: 10.1016/S0955-0674(00)00238-6
47. Kalra, H., Simpson, R. J., Ji, H., Aikawa, E., Altevogt, P., Askenase, P., et al. (2012). Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 10:e1001450. doi: 10.1371/journal.pbio.1001450
48. Kinoshita, T. (2014). Biosynthesis and deficiencies of glycosylphosphatidylinositol. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 90, 130-143. doi: 10.2183/pjab.90.130
49. Kinoshita, T., Maeda, Y., and Fujita, M. (2013). Transport of glycosylphosphatidylinositol-anchored proteins from the endoplasmic reticulum. Biochim. Biophys. Acta 1833, 2473-2478. doi: 10.1016/j.bbamcr.2013.01.027
50. Kohga, K., Takehara, T., Tatsumi, T., Ishida, H., Miyagi, T., Hosui, A., et al. (2010). Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9. Hepatology 51, 1264-1273. doi: 10.1002/hep.23456
51. Kohga, K., Takehara, T., Tatsumi, T., Miyagi, T., Ishida, H., Ohkawa, K., et al. (2009). Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma. Cancer Res. 69, 8050-8057. doi: 10.1158/0008-5472.CAN-09-0789
52. Labani-Motlagh, A., Israelsson, P., Ottander, U., Lundin, E., Nagaev, I., Nagaeva, O., et al. (2015). Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity. Tumour Biol. 37, 5455-5466. doi: 10.1007/s13277-015-4313-2
53. Laulagnier, K., Motta, C., Hamdi, S., Roy, S., Fauvelle, F., Pageaux, J. F., et al. (2004). Mast cell-and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem. J. 380, 161-171. doi: 10.1042/bj20031594
54. Laulagnier, K., Vincent-Schneider, H., Hamdi, S., Subra, C., Lankar, D., and Record, M. (2005). Characterization of exosome subpopulations from RBL-2H3 cells using fluorescent lipids. Blood Cells Mol. Dis. 35, 116-121. doi: 10.1016/j.bcmd.2005.05.010
55. Lee, H. D., Kim, Y. H., Koo, B. H., and Kim, D. S. (2015). The ADAM15 ectodomain is shed from secretory exosomes. BMB Rep. 48, 277-282. doi: 10.5483/BMBRep.2015.48.5.161
56. Liu, G., Atteridge, C. L., Wang, X., Lundgren, A. D., and Wu, J. D. (2010). The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases. J. Immunol. 184, 3346-3350. doi: 10.4049/jimmunol.0903789
57. Llorente, A., Skotland, T., Sylvanne, T., Kauhanen, D., Rog, T., Orlowski, A., et al. (2013). Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim. Biophys. Acta 1831, 1302-1309. doi: 10.1016/j.bbalip.2013.04.011
58. Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A., and Maihle, N. J. (1992). Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4, 96-100. doi: 10.1016/1043-4666(92)90043-Q
59. Ma, R., Gu, Y., Groome, L. J., and Wang, Y. (2011). ADAM17 regulates TNFalpha production by placental trophoblasts. Placenta 32, 975-980. doi: 10.1016/j.placenta.2011.09.015
60. Mathews, J. A., Gibb, D. R., Chen, B. H., Scherle, P., and Conrad, D. H. (2010). CD23 Sheddase A disintegrin and metalloproteinase 10 (ADAM10) is also required for CD23 sorting into B cell-derived exosomes. J. Biol. Chem. 285, 37531-37541. doi: 10.1074/jbc.M110.141556
61. Mathivanan, S., Fahner, C. J., Reid, G. E., and Simpson, R. J. (2012). ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 40, D1241-D1244. doi: 10.1093/nar/gkr828
62. Matusali, G., Tchidjou, H. K., Pontrelli, G., Bernardi, S., D'ettorre, G., Vullo, V., et al. (2013). Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. FASEB J. 27, 2440-2450. doi: 10.1096/fj.12-223057
63. Mizuki, N., Ota, M., Kimura, M., Ohno, S., Ando, H., Katsuyama, Y., et al. (1997). Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease. Proc. Natl. Acad. Sci. U.S.A. 94, 1298-1303. doi: 10.1073/pnas.94.4.1298
64. Morisaki, T., Hirano, T., Koya, N., Kiyota, A., Tanaka, H., Umebayashi, M., et al. (2014). NKG2D-directed cytokine-activated killer lymphocyte therapy combined with gemcitabine for patients with chemoresistant metastatic solid tumors. Anticancer Res. 34, 4529-4538
65. Morisaki, T., Onishi, H., Koya, N., Kiyota, A., Tanaka, H., Umebayashi, M., et al. (2011). Combinatorial cytotoxicity of gemcitabine and cytokine-activated killer cells in hepatocellular carcinoma via the NKG2D-MICA/B system. Anticancer Res. 31, 2505-2510
66. Muller, G., Jung, C., Straub, J., Wied, S., and Kramer, W. (2009). Induced release of membrane vesicles from rat adipocytes containing glycosylphosphatidylinositol-anchored microdomain and lipid droplet signalling proteins. Cell. Signal. 21, 324-338. doi: 10.1016/j.cellsig.2008.10.021
67. Muralidharan-Chari, V., Clancy, J., Plou, C., Romao, M., Chavrier, P., Raposo, G., et al. (2009). ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr. Biol. 19, 1875-1885. doi: 10.1016/j.cub.2009.09.059
68. Nausch, N., and Cerwenka, A. (2008). NKG2D ligands in tumor immunity. Oncogene 27, 5944-5958. doi: 10.1038/onc.2008.272
69. Nissi, R., Talvensaari-Mattila, A., Kotila, V., Niinimaki, M., Jarvela, I., and Turpeenniemi-Hujanen, T. (2013). Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure. Reprod. Biol. Endocrinol. 11:2. doi: 10.1186/1477-7827-11-2
70. Noel, A., Gutierrez-Fernandez, A., Sounni, N. E., Behrendt, N., Maquoi, E., Lund, I. K., et al. (2012). New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment. Front. Pharmacol. 3:140. doi: 10.3389/fphar.2012.00140
71. Ohashi, M., Eagle, R. A., and Trowsdale, J. (2010). Post-translational modification of the NKG2D ligand RAET1G leads to cell surface expression of a glycosylphosphatidylinositol-linked isoform. J. Biol. Chem. 285, 16408-16415. doi: 10.1074/jbc.M109.077636
72. Osteikoetxea, X., Balogh, A., Szabo-Taylor, K., Nemeth, A., Szabo, T. G., Paloczi, K., et al. (2015a). Improved characterization of EV preparations based on protein to lipid ratio and lipid properties. PLoS ONE 10:e0121184. doi: 10.1371/journal.pone.0121184
73. Osteikoetxea, X., Sodar, B., Nemeth, A., Szabo-Taylor, K., Paloczi, K., Vukman, K. V., et al. (2015b). Differential detergent sensitivity of extracellular vesicle subpopulations. Org. Biomol. Chem. 13, 9775-9782. doi: 10.1039/c5ob01451d
74. Ota, M., Katsuyama, Y., Mizuki, N., Ando, H., Furihata, K., Ono, S., et al. (1997). Trinucleotide repeat polymorphism within exon 5 of the MICA gene (MHC class I chain-related gene A): allele frequency data in the nine population groups Japanese, Northern Han, Hui, Uygur, Kazakhstan, Iranian, Saudi Arabian, Greek and Italian. Tissue Antigens 49, 448-454. doi: 10.1111/j.1399-0039.1997.tb02778.x
75. Paladino, S., Lebreton, S., and Zurzolo, C. (2015). Trafficking and membrane organization of GPI-anchored proteins in health and diseases. Curr. Top. Membr. 75, 269-303. doi: 10.1016/bs.ctm.2015.03.006
76. Raulet, D. H., Gasser, S., Gowen, B. G., Deng, W., and Jung, H. (2013). Regulation of ligands for the NKG2D activating receptor. Annu. Rev. Immunol. 31, 413-441. doi: 10.1146/annurev-immunol-032712-095951
77. Reyburn, H. T., Esteso, G., Ashiru, O., and Vales-Gomez, M. (2015). Viral strategies to modulate NKG2D-ligand expression in Human Cytomegalovirus infection. N. Horizons Trans. Med. 2, 159-166. doi: 10.1016/j.nhtm.2015.11.002
78. Salih, H. R., Holdenrieder, S., and Steinle, A. (2008). Soluble NKG2D ligands: prevalence, release, and functional impact. Front. Biosci. 13, 3448-3456. doi: 10.2741/2939
79. Salih, H. R., Rammensee, H. G., and Steinle, A. (2002). Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J. Immunol. 169, 4098-4102. doi: 10.4049/jimmunol.169.8.4098
80. Samuels, S., Ferns, D. M., Meijer, D., Van Straalen, J. P., Buist, M. R., Zijlmans, H. J., et al. (2015). High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma. Tissue Antigens 85, 476-483. doi: 10.1111/tan.12562
81. Schall, T. J., Lewis, M., Koller, K. J., Lee, A., Rice, G. C., Wong, G. H., et al. (1990). Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61, 361-370. doi: 10.1016/0092-8674(90)90816-W
82. Schumacher, N., Meyer, D., Mauermann, A., Von Der Heyde, J., Wolf, J., Schwarz, J., et al. (2015). Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles. J. Biol. Chem. 290, 26059-26071. doi: 10.1074/jbc.M115.649509
83. Schwinn, N., Vokhminova, D., Sucker, A., Textor, S., Striegel, S., Moll, I., et al. (2009). Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells. Int. J. Cancer 124, 1594-1604. doi: 10.1002/ijc.24098
84. Shen, B., Wu, N., Yang, J. M., and Gould, S. J. (2011). Protein targeting to exosomes/microvesicles by plasma membrane anchors. J. Biol. Chem. 286, 14383-14395. doi: 10.1074/jbc.M110.208660
85. Simons, K., and Ikonen, E. (1997). Functional rafts in cell membranes. Nature 387, 569-572. doi: 10.1038/42408
86. Skov, S., Pedersen, M. T., Andresen, L., Straten, P. T., Woetmann, A., and Odum, N. (2005). Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. Cancer Res. 65, 11136-11145. doi: 10.1158/0008-5472.CAN-05-0599
87. Spear, P., Wu, M. R., Sentman, M. L., and Sentman, C. L. (2013). NKG2D ligands as therapeutic targets. Cancer Immun. 13:8
88. Staubach, S., and Hanisch, F. G. (2011). Lipid rafts: signaling and sorting platforms of cells and their roles in cancer. Expert Rev. Proteomics 8, 263-277. doi: 10.1586/epr.11.2
89. Stoeck, A., Keller, S., Riedle, S., Sanderson, M. P., Runz, S., Le Naour, F., et al. (2006). A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem. J. 393, 609-618. doi: 10.1042/BJ20051013
90. Sun, D., Wang, X., Zhang, H., Deng, L., and Zhang, Y. (2011). MMP9 mediates MICA shedding in human osteosarcomas. Cell Biol. Int. 35, 569-574. doi: 10.1042/CBI20100431
91. Tan, S. S., Yin, Y., Lee, T., Lai, R. C., Yeo, R. W., Zhang, B., et al. (2013). Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane. J. Extracell. Vesicles 2, 22614-22624. doi: 10.3402/jev.v2i0.22614
92. Taylor, D. R., and Hooper, N. M. (2006). The prion protein and lipid rafts. Mol. Membr. Biol. 23, 89-99. doi: 10.1080/09687860500449994
93. Taylor, D. R., Parkin, E. T., Cocklin, S. L., Ault, J. R., Ashcroft, A. E., Turner, A. J., et al. (2009). Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J. Biol. Chem. 284, 22590-22600. doi: 10.1074/jbc.M109.032599
94. Tellier, E., Canault, M., Rebsomen, L., Bonardo, B., Juhan-Vague, I., Nalbone, G., et al. (2006). The shedding activity of ADAM17 is sequestered in lipid rafts. Exp. Cell Res. 312, 3969-3980. doi: 10.1016/j.yexcr.2006.08.027
95. Tsakadze, N. L., Sithu, S. D., Sen, U., English, W. R., Murphy, G., and D'souza, S. E. (2006). Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1). J. Biol. Chem. 281, 3157-3164. doi: 10.1074/jbc.M510797200
96. Upshaw, J. L., Arneson, L. N., Schoon, R. A., Dick, C. J., Billadeau, D. D., and Leibson, P. J. (2006). NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Nat. Immunol. 7, 524-532. doi: 10.1038/ni1325
97. Vales-Gomez, M. (2015). The Impact of Glycosyl-Phosphatidyl-Inositol Anchored MICA Alleles on Novel NKG2D-Based Therapies. Front. Immunol. 6:193. doi: 10.3389/fimmu.2015.00193
98. Vales-Gomez, M., Chisholm, S. E., Cassady-Cain, R. L., Roda-Navarro, P., and Reyburn, H. T. (2008). Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors. Cancer Res. 68, 1546-1554. doi: 10.1158/0008-5472.CAN-07-2973
99. Waldhauer, I., Goehlsdorf, D., Gieseke, F., Weinschenk, T., Wittenbrink, M., Ludwig, A., et al. (2008). Tumor-associated MICA is shed by ADAM proteases. Cancer Res. 68, 6368-6376. doi: 10.1158/0008-5472.CAN-07-6768
100. Waldhauer, I., and Steinle, A. (2006). Proteolytic release of soluble UL16-binding protein 2 from tumor cells. Cancer Res. 66, 2520-2526. doi: 10.1158/0008-5472.CAN-05-2520
101. Wik, L., Klingeborn, M., Willander, H., and Linne, T. (2012). Separate mechanisms act concurrently to shed and release the prion protein from the cell. Prion 6, 498-509. doi: 10.4161/pri.22588
102. Wubbolts, R., Leckie, R. S., Veenhuizen, P. T., Schwarzmann, G., Mobius, W., Hoernschemeyer, J., et al. (2003). Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J. Biol. Chem. 278, 10963-10972. doi: 10.1074/jbc.M207550200
103. Wu, J. D., Higgins, L. M., Steinle, A., Cosman, D., Haugk, K., and Plymate, S. R. (2004). Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J. Clin. Invest. 114, 560-568. doi: 10.1172/JCI200422206
104. Xu, X., Rao, G. S., Groh, V., Spies, T., Gattuso, P., Kaufman, H. L., et al. (2011). Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression. BMC Cancer 11:194. doi: 10.1186/1471-2407-11-194
105. Yadav, D., Ngolab, J., Lim, R. S., Krishnamurthy, S., and Bui, J. D. (2009). Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-gamma-induced microRNA. J. Immunol. 182, 39-43. doi: 10.4049/jimmunol.182.1.39
106. Yamanegi, K., Yamane, J., Kobayashi, K., Ohyama, H., Nakasho, K., Yamada, N., et al. (2012). Downregulation of matrix metalloproteinase-9 mRNA by valproic acid plays a role in inhibiting the shedding of MHC class I-related molecules A and B on the surface of human osteosarcoma cells. Oncol. Rep. 28, 1585-1590. doi: 10.3892/or.2012.1981
107. Zhang, C., Niu, J., Zhang, J., Wang, Y., Zhou, Z., and Tian, Z. (2008). Opposing effects of interferon-alpha and interferon-gamma on the expression of major histocompatibility complex class I chain-related A in tumors. Cancer Sci. 99, 1279-1286. doi: 10.1111/j.1349-7006.2008.00791.x
108. Zhang, H. G., Liu, C., Su, K., Yu, S., Zhang, L., Zhang, S., et al. (2006). A membrane form of TNF-alpha presented by exosomes delays T cell activation-induced cell death. J. Immunol. 176, 7385-7393. doi: 10.4049/jimmunol.176.12.7385
109. Zurzolo, C., and Simons, K. (2016). Glycosylphosphatidylinositol-anchored proteins: membrane organization and transport. Biochim. Biophys. Acta 1858, 632-639. doi: 10.1016/j.bbamem.2015.12.018